DE3435516A1 - Massen zur ausbildung von vesikeln - Google Patents
Massen zur ausbildung von vesikelnInfo
- Publication number
- DE3435516A1 DE3435516A1 DE19843435516 DE3435516A DE3435516A1 DE 3435516 A1 DE3435516 A1 DE 3435516A1 DE 19843435516 DE19843435516 DE 19843435516 DE 3435516 A DE3435516 A DE 3435516A DE 3435516 A1 DE3435516 A1 DE 3435516A1
- Authority
- DE
- Germany
- Prior art keywords
- carbon atoms
- hydrocarbon group
- vesicles
- group
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000004094 surface-active agent Substances 0.000 claims description 23
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 20
- -1 halogen ion Chemical class 0.000 claims description 12
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims description 5
- 229930195733 hydrocarbon Natural products 0.000 claims description 5
- 150000002500 ions Chemical class 0.000 claims description 5
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-O bis(2-hydroxyethyl)azanium Chemical compound OCC[NH2+]CCO ZBCBWPMODOFKDW-UHFFFAOYSA-O 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 3
- 239000000243 solution Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 17
- 239000002502 liposome Substances 0.000 description 16
- 239000003814 drug Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- JOLMGYIWICXNDT-UHFFFAOYSA-N 2-[dodecyl(methyl)amino]ethanol Chemical class CCCCCCCCCCCCN(C)CCO JOLMGYIWICXNDT-UHFFFAOYSA-N 0.000 description 1
- YAHRVXLYTUDZDX-UHFFFAOYSA-M 2-hydroxyethyl-methyl-di(tetradecyl)azanium chloride Chemical compound [Cl-].C(CCCCCCCCCCCCC)[N+](C)(CCO)CCCCCCCCCCCCCC YAHRVXLYTUDZDX-UHFFFAOYSA-M 0.000 description 1
- CSILTOSWFXCNOW-UHFFFAOYSA-N 2-hydroxyethyl-methyl-dioctadecylazanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(CCO)CCCCCCCCCCCCCCCCCC CSILTOSWFXCNOW-UHFFFAOYSA-N 0.000 description 1
- IYUAXZPNNRELOF-UHFFFAOYSA-M 2-hydroxyethyl-methyl-dioctadecylazanium bromide Chemical compound [Br-].C(CCCCCCCCCCCCCCCCC)[N+](C)(CCO)CCCCCCCCCCCCCCCCCC IYUAXZPNNRELOF-UHFFFAOYSA-M 0.000 description 1
- QETYTJIBLNPZHF-UHFFFAOYSA-M 2-hydroxyethyl-methyl-dioctadecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(CCO)CCCCCCCCCCCCCCCCCC QETYTJIBLNPZHF-UHFFFAOYSA-M 0.000 description 1
- NQACPPULWUTWKR-UHFFFAOYSA-M 2-hydroxyethyl-methyl-dioctadecylazanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCC[N+](C)(CCO)CCCCCCCCCCCCCCCCCC NQACPPULWUTWKR-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- RNSFZASKQKOXAS-UHFFFAOYSA-M C(C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)[N+](C)(CCO)CCCCCCCCCCCCCCCCCC Chemical compound C(C)(=O)[O-].C(CCCCCCCCCCCCCCCCC)[N+](C)(CCO)CCCCCCCCCCCCCCCCCC RNSFZASKQKOXAS-UHFFFAOYSA-M 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- JGFDZZLUDWMUQH-UHFFFAOYSA-N Didecyldimethylammonium Chemical class CCCCCCCCCC[N+](C)(C)CCCCCCCCCC JGFDZZLUDWMUQH-UHFFFAOYSA-N 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- TXQVDVNAKHFQPP-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)CO TXQVDVNAKHFQPP-UHFFFAOYSA-N 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- MQWVSQIVACGLLU-UHFFFAOYSA-M benzyl-didecyl-methylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(CCCCCCCCCC)CC1=CC=CC=C1 MQWVSQIVACGLLU-UHFFFAOYSA-M 0.000 description 1
- OZISYDUERWIGSU-UHFFFAOYSA-M benzyl-didodecyl-methylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CC1=CC=CC=C1 OZISYDUERWIGSU-UHFFFAOYSA-M 0.000 description 1
- LWTUMPIEDGALLK-UHFFFAOYSA-M benzyl-methyl-dioctadecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 LWTUMPIEDGALLK-UHFFFAOYSA-M 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- OCTAKUVKMMLTHX-UHFFFAOYSA-M di(icosyl)-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCCCC OCTAKUVKMMLTHX-UHFFFAOYSA-M 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- XUXZYMCUMKODKW-UHFFFAOYSA-N didecyl-(2-hydroxyethyl)-methylazanium Chemical class CCCCCCCCCC[N+](C)(CCO)CCCCCCCCCC XUXZYMCUMKODKW-UHFFFAOYSA-N 0.000 description 1
- PAFRZNKCTXARNY-UHFFFAOYSA-M didecyl-(2-hydroxyethyl)-methylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(CCO)CCCCCCCCCC PAFRZNKCTXARNY-UHFFFAOYSA-M 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- QQJDHWMADUVRDL-UHFFFAOYSA-N didodecyl(dimethyl)azanium Chemical class CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC QQJDHWMADUVRDL-UHFFFAOYSA-N 0.000 description 1
- WLCFKPHMRNPAFZ-UHFFFAOYSA-M didodecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC WLCFKPHMRNPAFZ-UHFFFAOYSA-M 0.000 description 1
- SWSFKKWJEHRFFP-UHFFFAOYSA-N dihexadecyl(dimethyl)azanium Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC SWSFKKWJEHRFFP-UHFFFAOYSA-N 0.000 description 1
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
- KQSBAORQSXKBIP-UHFFFAOYSA-N dihexadecyl-(2-hydroxyethyl)-methylazanium Chemical class CCCCCCCCCCCCCCCC[N+](C)(CCO)CCCCCCCCCCCCCCCC KQSBAORQSXKBIP-UHFFFAOYSA-N 0.000 description 1
- XICSHSCSQMDVQC-UHFFFAOYSA-M dihexadecyl-(2-hydroxyethyl)-methylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCO)CCCCCCCCCCCCCCCC XICSHSCSQMDVQC-UHFFFAOYSA-M 0.000 description 1
- PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 1
- BHOMVMDILSNYRL-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC BHOMVMDILSNYRL-UHFFFAOYSA-M 0.000 description 1
- FPDLLPXYRWELCU-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC FPDLLPXYRWELCU-UHFFFAOYSA-M 0.000 description 1
- CJBMLKNLJXFFGD-UHFFFAOYSA-N dimethyl-di(tetradecyl)azanium Chemical class CCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCC CJBMLKNLJXFFGD-UHFFFAOYSA-N 0.000 description 1
- RSHHCURRBLAGFA-UHFFFAOYSA-M dimethyl-di(tetradecyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCC RSHHCURRBLAGFA-UHFFFAOYSA-M 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- KGOGNDXXUVELIQ-UHFFFAOYSA-N dioctadecylazanium;chloride Chemical compound Cl.CCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCC KGOGNDXXUVELIQ-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- QUUIOUDBHCQMPZ-UHFFFAOYSA-M ethyl sulfate 2-hydroxyethyl-methyl-dioctadecylazanium Chemical compound C(C)OS(=O)(=O)[O-].C(CCCCCCCCCCCCCCCCC)[N+](C)(CCO)CCCCCCCCCCCCCCCCCC QUUIOUDBHCQMPZ-UHFFFAOYSA-M 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XGZOMURMPLSSKQ-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCO XGZOMURMPLSSKQ-UHFFFAOYSA-N 0.000 description 1
- UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- HCYWSHCYEUEVRZ-UHFFFAOYSA-M sodium N-dodecylcarbamate Chemical compound C(CCCCCCCCCCC)NC(=O)[O-].[Na+] HCYWSHCYEUEVRZ-UHFFFAOYSA-M 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000007332 vesicle formation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58181629A JPS6072831A (ja) | 1983-09-29 | 1983-09-29 | ベシクル用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3435516A1 true DE3435516A1 (de) | 1985-04-18 |
Family
ID=16104113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19843435516 Withdrawn DE3435516A1 (de) | 1983-09-29 | 1984-09-27 | Massen zur ausbildung von vesikeln |
Country Status (4)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4107152A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparate zur nichtinvasiven verabreichung von antidiabetica |
| DE4107153A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparat zur wirkstoffapplikation in kleinsttroepfchenform |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855090A (en) * | 1987-03-13 | 1989-08-08 | Micro-Pak, Inc. | Method of producing high aqueous volume multilamellar vesicles |
| US5023086A (en) * | 1987-03-13 | 1991-06-11 | Micro-Pak, Inc. | Encapsulated ionophore growth factors |
| US5000960A (en) * | 1987-03-13 | 1991-03-19 | Micro-Pak, Inc. | Protein coupling to lipid vesicles |
| US5234767A (en) * | 1987-03-13 | 1993-08-10 | Micro-Pak, Inc. | Hybrid paucilamellar lipid vesicles |
| US4942038A (en) * | 1987-03-13 | 1990-07-17 | Micro Vesicular Systems, Inc. | Encapsulated humectant |
| US4917951A (en) * | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US4911928A (en) * | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US5628936A (en) * | 1987-03-13 | 1997-05-13 | Micro-Pak, Inc. | Hybrid paucilamellar lipid vesicles |
| US4853228A (en) * | 1987-07-28 | 1989-08-01 | Micro-Pak, Inc. | Method of manufacturing unilamellar lipid vesicles |
| US5032457A (en) * | 1988-03-03 | 1991-07-16 | Micro Vesicular Systems, Inc. | Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants |
| US5019392A (en) * | 1988-03-03 | 1991-05-28 | Micro-Pak, Inc. | Encapsulation of parasiticides |
| US5160669A (en) * | 1988-03-03 | 1992-11-03 | Micro Vesicular Systems, Inc. | Method of making oil filled paucilamellar lipid vesicles |
| US5019174A (en) * | 1988-03-03 | 1991-05-28 | Micro Vesicular Systems, Inc. | Removing oil from surfaces with liposomal cleaner |
| US5104736A (en) * | 1988-03-03 | 1992-04-14 | Micro-Pak, Inc. | Reinforced paucilamellar lipid vesicles |
| US5164191A (en) * | 1991-02-12 | 1992-11-17 | Micro Vesicular Systems, Inc. | Lipid vesicles having an alkyd as a wall-forming material |
| US5213805A (en) * | 1991-07-25 | 1993-05-25 | Micro Vesicular Systems, Inc. | Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid |
| US5260065A (en) * | 1991-09-17 | 1993-11-09 | Micro Vesicular Systems, Inc. | Blended lipid vesicles |
| US5643600A (en) * | 1991-09-17 | 1997-07-01 | Micro-Pak, Inc. | Lipid vesicles containing avocado oil unsaponifiables |
| US5439967A (en) * | 1991-09-17 | 1995-08-08 | Micro Vesicular Systems, Inc. | Propylene glycol stearate vesicles |
| US5405615A (en) * | 1991-09-17 | 1995-04-11 | Micro Vesicular Systems, Inc. | Sucrose distearate lipid vesicles |
| FR2687313A1 (fr) * | 1992-02-17 | 1993-08-20 | Oreal | Dispersion de vesicules a base de betauines et compositions cosmetiques et/ou pharmaceutiques contenant ladite dispersion. |
| US5753613A (en) * | 1994-09-30 | 1998-05-19 | Inex Pharmaceuticals Corporation | Compositions for the introduction of polyanionic materials into cells |
| EP1179340A3 (en) * | 1994-09-30 | 2003-05-07 | INEX Pharmaceutical Corp. | Compositions for the introduction of polyanionic materials into cells |
| US7749520B2 (en) | 2004-07-07 | 2010-07-06 | Statens Serum Institut | Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3753990A (en) * | 1972-01-17 | 1973-08-21 | Procter & Gamble | Phenylbismuth bis(2-pyridinethiol 1-oxide) |
| US3974076A (en) * | 1974-01-11 | 1976-08-10 | The Procter & Gamble Company | Fabric softener |
| FR2315991A1 (fr) * | 1975-06-30 | 1977-01-28 | Oreal | Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes |
| JPS6014146B2 (ja) * | 1977-01-29 | 1985-04-11 | ライオン株式会社 | 繊維柔軟化組成物 |
| JPS53134784A (en) * | 1977-04-28 | 1978-11-24 | Kao Corp | Production of small hollow cell-containing material consisting of double layers of surface active agent |
| FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
| US4233164A (en) * | 1979-06-05 | 1980-11-11 | The Proctor & Gamble Company | Liquid fabric softener |
| ATE8584T1 (de) * | 1980-01-16 | 1984-08-15 | Hans Georg Prof. Dr. Weder | Verfahren und dialysiereinrichtung zur herstellung von bilayer-vesikeln und verwendung der bilayer-vesikel. |
| GR77320B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1980-12-22 | 1984-09-11 | Procter & Gamble | |
| EP0067635A3 (en) * | 1981-06-15 | 1984-02-22 | THE PROCTER & GAMBLE COMPANY | Shampoo compositions |
| EP0102324A3 (de) * | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
-
1983
- 1983-09-29 JP JP58181629A patent/JPS6072831A/ja active Granted
-
1984
- 1984-09-07 GB GB08422628A patent/GB2147263B/en not_active Expired
- 1984-09-27 DE DE19843435516 patent/DE3435516A1/de not_active Withdrawn
- 1984-09-28 FR FR8414910A patent/FR2552679B1/fr not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4107152A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparate zur nichtinvasiven verabreichung von antidiabetica |
| DE4107153A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparat zur wirkstoffapplikation in kleinsttroepfchenform |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2552679A1 (fr) | 1985-04-05 |
| GB8422628D0 (en) | 1984-10-10 |
| JPH0326166B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1991-04-10 |
| GB2147263A (en) | 1985-05-09 |
| FR2552679B1 (fr) | 1993-06-11 |
| GB2147263B (en) | 1987-03-25 |
| JPS6072831A (ja) | 1985-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3435516A1 (de) | Massen zur ausbildung von vesikeln | |
| DE2629100C3 (de) | Dispersion von Kügelchen und Verfahren zu ihrer Herstellung | |
| DE2207294C2 (de) | Topische Salbengrundlage | |
| DE69216650T2 (de) | Analgetische Zusammensetzungen | |
| DE69104079T3 (de) | Sirup. | |
| DE69935435T2 (de) | Mittels Ammoniumsulfatgradient hergestellte liposomale analgetische Zusammensetzungen | |
| DE60216634T2 (de) | Gel mit mindestens einem retinoid und benzoylperoxid | |
| DE69317444T2 (de) | Antivirale topische pharmazeutische zusammensetzungen | |
| DE60121016T2 (de) | Polymere mizelle mit darin eingeschlossenem cisplatin und ihre verwendung | |
| DE60118483T2 (de) | Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung | |
| DE69711237T2 (de) | Lokalanästhetikum zur aüsserlichen anwendung | |
| DE3111767A1 (de) | Mittel zur behandlung der haut | |
| DE2416736A1 (de) | Neue arzneimittelzubereitungen in form von waessrigen suspensionen | |
| DE69302396T2 (de) | Antiviral wirksame pharmazeutische öl in wasser-emulsion, die 9-[(2-hydroxyethoxy)methyl]-guanin (acyclovir) oder ein salz oder einen ester davon enthält | |
| DD266506A5 (de) | Verfahren zur herstellung einer pharmazeutischen band-zusammensetzung | |
| DE3435517A1 (de) | Vesikel bildende massen | |
| DE3402880A1 (de) | Oel-in-wasser-creme und verfahren zu ihrer herstellung | |
| DE102005063375A1 (de) | Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen | |
| DE3852409T2 (de) | Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen. | |
| DE19730408B4 (de) | Zusammensetzung für äußere Anwendung | |
| AT379309B (de) | Verfahren zur herstellung einer topischen benzoylperoxidzusammensetzung | |
| DE2234474C3 (de) | Verfahren zur Herstellung fein verteilter Mikropartikel von Tyrosin mit einem Gehalt eines darin dispergierten Allergens und diese Produkte enthaltende Arzneipräparate | |
| DE4038385C2 (de) | Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit | |
| DE69122810T2 (de) | Liposomen | |
| EP0615746B1 (de) | Wässriges Liposomensystem sowie Verfahren zur Herstellung eines derartigen Liposomensystems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination |